Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: Case report and strain characterization

Diagnostic Microbiology and Infectious Disease

Volumn 45, Issue 2, 2003, Pages 149-152

  Andrade Baiocchi, Soraya ^a   Tognim, Maria Cristina B ^a   Baiocchi, Otavio C G ^a   Sader, Helio S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Endocarditis; GISA; Linezolid; Multiple myeloma; Vancomycin resistance; Vancomycin intermediate Staphylococcus aureus; VISA

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; GLYCOPEPTIDE; LINEZOLID; RIFAMPICIN; VANCOMYCIN; VINCRISTINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BACTERIUM ISOLATE; CANCER CHEMOTHERAPY; CASE REPORT; DISEASE COURSE; DRUG MEGADOSE; FEMALE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIPLE MYELOMA; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 0037332045     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00511-4     Document Type: Article

References (10)

1. Staphylococcus aureus resistant to vancomycin - United States. MMWR. 51:2002;565-567.
2. Gales A.C., Jones R.N., Pfaller M.A., Gordon K.A., Sader H.S. A two year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals results from the SENTRY Antimicrobial Surveillance Program. Int J Infect Dis. 4:2000;75-84.
3. Hiramatsu K., Hanaki H., Ino T., Yabuta K., Oguri T., Tenover F.C. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother. 40:1997;135-136.
4. Howe R.A., Wootton M., Walsh T.R., Bennett P.M., Macgowan A.P. Expression and detection of hetero-vancomycin resistance in Staphylococcus aureus. J Antimicrob Chemother. 44:1999;675-678.
5. National Committee for Clinical Laboratory Standards. (2000). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standart M7-A5. National Committee for Clinical Laboratory Standards, Wayne, PA.
6. Sader H.S., Pignatari A.C., Hollis R.J., Jones R.N. Evaluation of interhospital spread of methicillin-resistant Staphylococcus aureus in Sao Paulo, Brazil, using pulsed-field gel electrophoresis of chromosomal DNA. Infect Control Hosp Epidemiol. 15:1994;320-323.
7. Sieradzki K., Tomasz A. Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus. J Bacteriol. 181:1999;7566-7570.
8. Sieradzki K., Tomasz A. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J Bacteriol. 179:1997;2557-2566.
9. Smith T.L., Pearson M.L., Wilcox K.R., Cruz C., Lancaster M.V., Robinson-Dunn B., Tenover F.C., Zervos M.J., Band J.D., White E., Jarvis W.R. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med. 340:1999;493-501.
10. Tenover F.C., Lancaster M.V., Hill B.C., Steward C.D., Stocker S.A., Hancock G.A., O'Hara C.M., Clark N.C., Hiramatsu K. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol. 36:1998;1020-1027.